Cancer Diagnostics

Exome, Array and Single-gene Cancer Diagnostics

“The incorporation of whole-genome and whole-exome sequencing into clinical practice will undoubtedly change the way genetic counselors and other clinicians approach genetic testing. Enabling the analysis of essentially all human genes in one comprehensive test, this new technology can result in reduced testing cost and time to diagnosis (O’Daniel et al, Cancer J. 2012 Jul;18(4).”

Genatak has developed a comprehensive range of cancer tests based on cutting-edge genomics and proteomics technologies. We offer the following services for cancer diagnostics and research:

  1. Whole-genome cancer sequencing – including detailed bioinformatics and clinical reporting
  2. Whole-exome cancer sequencing – including detailed bioinformatics and clinical reporting
  3. Whole-genome array based cancer analysis
  4. Haematological cancers – detection of copy number changes and loss of heterozygosity on a single array for the haematological malignancies Chronic Lymphocytic Leukaemia (CLL), Multiple Myeloma (MM), Myeloproliferative Neoplasms (MPN) and Myelodysplastic Syndromes (MDS)
  5. Fluorescent in situ hybridisation (FISH) on FFPE sections for copy number estimation and translocations in a variety of solid tumours including Her2 gene amplification in breast cancer
oligodendroglioma

Need a Quote?

Fill in our
10 second - 1 click
form here

Request a Quote

How to order

Learn More Here